Key Highlights
- Partnership to expand molecular testing across European and UK markets.
- Focus on rapid, in-house cancer diagnosis using NGS liquid biopsy panels.
- Pillar’s oncoRevealTM LBx panels offer high sensitivity with results in less than three days.
- Scalable sequencing for economic value using Illumina NextSeq™.
Source: PR Newswire
Notable Quotes
- “Access to cost-effective, easy-to-use, distributed NGS kits for liquid biopsy testing are critical to support local laboratories in providing clinically actionable results to oncologists and supporting critical treatment decisions for cancer patients globally.” — Dan Harma, Chief Commercial Officer at Pillar Biosciences
- “We are committed to expanding global patient access to biomarker testing, and decentralized NGS solutions are key to this strategy.” — John Longshore, Head of Scientific Affairs, Global Oncology Diagnostics at AstraZeneca
SoHC's Take
This strategic partnership between Pillar Biosciences and AstraZeneca is a significant development in cancer diagnostics, especially in the European and UK markets. The ability to offer rapid and scalable Next Generation Sequencing (NGS) liquid biopsy tumor profiling empowers local laboratories to perform complex cancer diagnostics in-house. By reducing turnaround times from weeks to just a few days, Pillar’s oncoRevealTM LBx panels not only increase efficiency but also enhance clinical decision-making. This collaboration highlights the importance of decentralized testing in improving global access to precision oncology treatments.
Heading
Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
